366 related articles for article (PubMed ID: 7453783)
1. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins.
Chenoweth DE; Cooper SW; Hugli TE; Stewart RW; Blackstone EH; Kirklin JW
N Engl J Med; 1981 Feb; 304(9):497-503. PubMed ID: 7453783
[TBL] [Abstract][Full Text] [Related]
2. Complement activation and neutropenia occurring during cardiopulmonary bypass.
Hammerschmidt DE; Stroncek DF; Bowers TK; Lammi-Keefe CJ; Kurth DM; Ozalins A; Nicoloff DM; Lillehei RC; Craddock PR; Jacob HS
J Thorac Cardiovasc Surg; 1981 Mar; 81(3):370-7. PubMed ID: 6970304
[TBL] [Abstract][Full Text] [Related]
3. [Use of cardiopulmonary bypass decreases leukocyte count and activation of the complement system].
Bochenek A; Religa Z; Kokot F; Knapik P; Wnuk R; Komarski K; Wojnar J; Pietrzycki A; Skiba J
Kardiol Pol; 1992; 36(2):67-72. PubMed ID: 1583828
[TBL] [Abstract][Full Text] [Related]
4. Complement activation during cardiopulmonary bypass. Comparison of bubble and membrane oxygenators.
Cavarocchi NC; Pluth JR; Schaff HV; Orszulak TA; Homburger HA; Solis E; Kaye MP; Clancy MS; Kolff J; Deeb GM
J Thorac Cardiovasc Surg; 1986 Feb; 91(2):252-8. PubMed ID: 3511328
[TBL] [Abstract][Full Text] [Related]
5. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
Langone JJ; Das C; Bennett D; Terman DS
J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
[TBL] [Abstract][Full Text] [Related]
6. Complement activation and anaphylatoxin (C3a and C5a) formation in preeclampsia and by amniotic fluid.
Haeger M; Bengtson A; Karlsson K; Heideman M
Obstet Gynecol; 1989 Apr; 73(4):551-6. PubMed ID: 2784554
[TBL] [Abstract][Full Text] [Related]
7. [Activation of complement during cardiopulmonary bypass--comparative study using 4 different oxygenators].
Soejima K; Koyanagi H; Endo M; Hashimoto A; Imai Y
Nihon Kyobu Geka Gakkai Zasshi; 1987 Feb; 35(2):200-4. PubMed ID: 3495614
[No Abstract] [Full Text] [Related]
8. [Atopic dermatitis. II. The status of complement proteins and the pathogenetic role of anaphylatoxins C4a, C3a and C5a].
Sergeev IuV; Reznikov IuP; Lobanova EV; Pimenova NS
Vestn Dermatol Venerol; 1989; (4):4-7. PubMed ID: 2788339
[TBL] [Abstract][Full Text] [Related]
9. Anaphylatoxin levels in human aqueous humor.
Mondino BJ; Sumner H
Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1288-92. PubMed ID: 3488296
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the anaphylatoxin inactivator and chemotactic factor inactivator activities during cardiopulmonary bypass.
Kreutzer DL; McCormick JR; Despins A; Moore M; Rousou JH; Dobbs W; Engleman RN
J Exp Pathol; 1984; 1(3):183-7. PubMed ID: 6336305
[TBL] [Abstract][Full Text] [Related]
11. Anaphylatoxin generation in multisystem organ failure.
Heideman M; Hugli TE
J Trauma; 1984 Dec; 24(12):1038-43. PubMed ID: 6334754
[TBL] [Abstract][Full Text] [Related]
12. Complement activation during cardiopulmonary bypass in infants and children. Relation to postoperative multiple system organ failure.
Seghaye MC; Duchateau J; Grabitz RG; Faymonville ML; Messmer BJ; Buro-Rathsmann K; von Bernuth G
J Thorac Cardiovasc Surg; 1993 Dec; 106(6):978-87. PubMed ID: 8246580
[TBL] [Abstract][Full Text] [Related]
13. Complement activation during systemic lupus erythematosus. C3a and C5a anaphylatoxins circulate during exacerbations of disease.
Belmont HM; Hopkins P; Edelson HS; Kaplan HB; Ludewig R; Weissmann G; Abramson S
Arthritis Rheum; 1986 Sep; 29(9):1085-9. PubMed ID: 3489467
[TBL] [Abstract][Full Text] [Related]
14. Plasma lactoferrin reflects granulocyte activation via complement in burn patients.
Wolach B; Coates TD; Hugli TE; Baehner RL; Boxer LA
J Lab Clin Med; 1984 Feb; 103(2):284-93. PubMed ID: 6607301
[TBL] [Abstract][Full Text] [Related]
15. [A study on complement activation in cardiopulmonary bypass--experimental and clinical evaluations].
Yamasaki M
Nihon Kyobu Geka Gakkai Zasshi; 1989 Feb; 37(2):234-41. PubMed ID: 2788676
[TBL] [Abstract][Full Text] [Related]
16. Significance of the concentrated red cell and albumin priming method with particular reference to anaphylatoxin generation.
Tamiya T; Maeo Y; Okada T; Ogoshi S; Fujimoto S; Yasui H
J Thorac Cardiovasc Surg; 1992 Jan; 103(1):78-86. PubMed ID: 1728718
[TBL] [Abstract][Full Text] [Related]
17. Anaphylatoxin formation in extracorporeal circuits.
Chenoweth DE
Complement; 1986; 3(3):152-65. PubMed ID: 3492330
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis.
Arnaout MA; Hakim RM; Todd RF; Dana N; Colten HR
N Engl J Med; 1985 Feb; 312(8):457-62. PubMed ID: 3881672
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of complement activation by high-dose corticosteroids in total hip arthroplasty.
Gammer W; Bengtson A; Heideman M
Clin Orthop Relat Res; 1988 Nov; (236):205-9. PubMed ID: 3263243
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary injury induced by C3a and C5a anaphylatoxins.
Stimler NP; Hugli TE; Bloor CM
Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
